|
Originally published In Press as doi:10.1074/jbc.M108398200 on November 29, 2001
J. Biol. Chem., Vol. 277, Issue 8, 5891-5901, February 22, 2002
Constitutive Internalization of Constitutively Active Angiotensin
II AT1A Receptor Mutants Is Blocked by Inverse
Agonists*
Stéphanie
Miserey-Lenkei ,
Charles
Parnot ,
Sabine
Bardin ,
Pierre
Corvol§, and
Eric
Clauser ¶
From INSERM EPI 0103, Institut Cochin, 24 rue du
Faubourg Saint-Jacques, 75014 Paris, France and § INSERM
U36, Collège de France, 11 place Marcelin Berthelot,
75005 Paris, France
As constitutively active mutants (CAMs) mimic an
active conformation, they can be used to characterize the process of G
protein-coupled receptor activation. Here, we used CAMs to study the
link between activation and internalization of the angiotensin II
AT1A receptor. The cellular localization of
fluorescently tagged N111A, I245T, and L305Q mutants was determined by
confocal microscopy. In the absence of ligand, CAMs were mostly located
in intracellular vesicles, whereas the wild-type AT1A was
found at the cell surface. After 2 h incubation with inverse
agonist, losartan, CAMs were translocated to the plasma membrane.
Similar observations were made in H295, a human adrenocortical cell
line which expresses physiologically the AT1 receptor. This
phenomenon, which was not dependent on protein synthesis and the
pharmacology and kinetics of which were similar to the recycling of the
wild-type receptor, was called "externalization". After
externalization and losartan removal, the L305Q CAM underwent rapid
ligand-independent endocytocis, with the same kinetics and temperature
sensitivity as the angiotensin II-induced internalization of the
wild-type AT1A. Moreover, the addition of a second mutation
known to block internalization ( 329 truncation) prevented
intracellular localization of the CAM. These data show that
AT1A CAMs are constitutively and permanently internalized and recycled. This mechanism is different from the down-regulation observed for CAMs of other G protein-coupled receptors and thus defines
a new paradigm for the cellular regulation of CAMs.
*
This work was supported by Grant 98126 from H scht Marion
Roussel and the Institut National Pour la Santé and la Recherche Médicale (INSERM).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: INSERM EPI
0103-ICGM, Faculté de Médecine Cochin, Port Royal, 24 rue
du Fg St Jacques, 75014 Paris, France. Tel.: 33-1-53-73-27-50; Fax:
33-1-53-73-27-51; E-mail: clauser@cochin.inserm.fr.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Kocan, H. B. See, N. G. Sampaio, K. A. Eidne, B. J. Feldman, and K. D. G. Pfleger
Agonist-Independent Interactions between {beta}-Arrestins and Mutant Vasopressin Type II Receptors Associated with Nephrogenic Syndrome of Inappropriate Antidiuresis
Mol. Endocrinol.,
April 1, 2009;
23(4):
559 - 571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Thieme, D. M. N. Eguti, M. Mello-Aires, and M. Oliveira-Souza
The effect of angiotensin II on intracellular pH is mediated by AT1 receptor translocation
Am J Physiol Cell Physiol,
July 1, 2008;
295(1):
C138 - C145.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Walwyn, C. J. Evans, and T. G. Hales
{beta}-Arrestin2 and c-Src Regulate the Constitutive Activity and Recycling of {micro} Opioid Receptors in Dorsal Root Ganglion Neurons
J. Neurosci.,
May 9, 2007;
27(19):
5092 - 5104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Oliveira, C. M. Costa-Neto, C. R. Nakaie, S. Schreier, S. I. Shimuta, and A. C. M. Paiva
The Angiotensin II AT1 Receptor Structure-Activity Correlations in the Light of Rhodopsin Structure
Physiol Rev,
April 1, 2007;
87(2):
565 - 592.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Cook, S. J. Mills, R. T. Naquin, J. Alam, and R. N. Re
Cleavage of the angiotensin II type 1 receptor and nuclear accumulation of the cytoplasmic carboxy-terminal fragment
Am J Physiol Cell Physiol,
April 1, 2007;
292(4):
C1313 - C1322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. M. D. Santos, L. A. Gardner, S. W. White, and S. W. Bahouth
Characterization of the Residues in Helix 8 of the Human beta1-Adrenergic Receptor That Are Involved in Coupling the Receptor to G Proteins
J. Biol. Chem.,
May 5, 2006;
281(18):
12896 - 12907.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Billet, S. Bardin, R. Tacine, E. Clauser, and S. Conchon
The AT1A receptor "gain-of-function" mutant N111S/{Delta}329 is both constitutively active and hyperreactive to angiotensin II
Am J Physiol Endocrinol Metab,
May 1, 2006;
290(5):
E840 - E848.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Leterrier, J. Laine, M. Darmon, H. Boudin, J. Rossier, and Z. Lenkei
Constitutive activation drives compartment-selective endocytosis and axonal targeting of type 1 cannabinoid receptors.
J. Neurosci.,
March 22, 2006;
26(12):
3141 - 3153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Wang, C. G. Radu, L. V. Yang, L. A. Bentolila, M. Riedinger, and O. N. Witte
Lysophosphatidylcholine-induced Surface Redistribution Regulates Signaling of the Murine G Protein-coupled Receptor G2A
Mol. Biol. Cell,
May 1, 2005;
16(5):
2234 - 2247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Robert, E. Clauser, P. X. Petit, and M. A. Ventura
A Novel C-terminal Motif Is Necessary for the Export of the Vasopressin V1b/V3 Receptor to the Plasma Membrane
J. Biol. Chem.,
January 21, 2005;
280(3):
2300 - 2308.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Holst, N. D. Holliday, A. Bach, C. E. Elling, H. M. Cox, and T. W. Schwartz
Common Structural Basis for Constitutive Activity of the Ghrelin Receptor Family
J. Biol. Chem.,
December 17, 2004;
279(51):
53806 - 53817.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Xia, S. Kjaer, K. Zheng, P.-S. Hu, L. Bai, J.-Y. Jia, R. Rigler, A. Pramanik, T. Xu, T. Hokfelt, et al.
Visualization of a functionally enhanced GFP-tagged galanin R2 receptor in PC12 cells: Constitutive and ligand-induced internalization
PNAS,
October 19, 2004;
101(42):
15207 - 15212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P. Morris, R. R. Price, M. P. Smith, B. Lei, and D. A. Schwinn
Cellular Trafficking of Human {alpha}1a-Adrenergic Receptors Is Continuous and Primarily Agonist-Independent
Mol. Pharmacol.,
October 1, 2004;
66(4):
843 - 854.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Santhamma, R. Sadhukhan, M. Kinter, S. Chattopadhyay, B. McCue, and I. Sen
Role of Tyrosine Phosphorylation in the Regulation of Cleavage Secretion of Angiotensin-converting Enzyme
J. Biol. Chem.,
September 17, 2004;
279(38):
40227 - 40236.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Leterrier, D. Bonnard, D. Carrel, J. Rossier, and Z. Lenkei
Constitutive Endocytic Cycle of the CB1 Cannabinoid Receptor
J. Biol. Chem.,
August 20, 2004;
279(34):
36013 - 36021.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Bernier, M. Lagace, M. Lonergan, M.-F. Arthus, D. G. Bichet, and M. Bouvier
Functional Rescue of the Constitutively Internalized V2 Vasopressin Receptor Mutant R137H by the Pharmacological Chaperone Action of SR49059
Mol. Endocrinol.,
August 1, 2004;
18(8):
2074 - 2084.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Takezako, C. Gogonea, Y. Saad, K. Noda, and S. S. Karnik
"Network Leaning" as a Mechanism of Insurmountable Antagonism of the Angiotensin II Type 1 Receptor by Non-peptide Antagonists
J. Biol. Chem.,
April 9, 2004;
279(15):
15248 - 15257.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Milligan
Constitutive Activity and Inverse Agonists of G Protein-Coupled Receptors: a Current Perspective
Mol. Pharmacol.,
December 1, 2003;
64(6):
1271 - 1276.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F.-Y. Zeng, A. J. McLean, G. Milligan, M. Lerner, D. T. Chalmers, and D. P. Behan
Ligand Specific Up-Regulation of a Renilla reniformis Luciferase-Tagged, Structurally Unstable Muscarinic M3 Chimeric G Protein-Coupled Receptor
Mol. Pharmacol.,
December 1, 2003;
64(6):
1474 - 1484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Auger-Messier, M. Clement, P. M. Lanctot, P. C. Leclerc, R. Leduc, E. Escher, and G. Guillemette
The Constitutively Active N111G-AT1 Receptor for Angiotensin II Maintains a High Affinity Conformation Despite Being Uncoupled from Its Cognate G Protein Gq/11{alpha}
Endocrinology,
December 1, 2003;
144(12):
5277 - 5284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Waldhoer, P. Casarosa, M. M. Rosenkilde, M. J. Smit, R. Leurs, J. L. Whistler, and T. W. Schwartz
The Carboxyl Terminus of Human Cytomegalovirus-encoded 7 Transmembrane Receptor US28 Camouflages Agonism by Mediating Constitutive Endocytosis
J. Biol. Chem.,
May 23, 2003;
278(21):
19473 - 19482.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Rochdi and J.-L. Parent
Galpha q-coupled Receptor Internalization Specifically Induced by Galpha q Signaling. REGULATION BY EBP50
J. Biol. Chem.,
May 9, 2003;
278(20):
17827 - 17837.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|